Forecasting PARP Inhibitor Resistance in Breast Cancer Patients

In this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in ovarian cancer, and the importance of understanding how resistance to these agents develops.

Source: CancerNetwork - April 23, 2018 Category: Cancer & Oncology Authors: Elizabeth Swisher, MD Tags: Conferences/AACR Street Team Breast Cancer News Source Type: news